Filing Flows › Viemed Healthcare (VMD) › R&D spending
Viemed Healthcare (VMD) R&D spending by quarter
Viemed Healthcare's R&D spending was $501K in Q3 2026 (third quarter 2026), -0.6% from Q2 2026. Over the last 7 quarters it ranged from $501K (Q3 2026) to $847K (Q2 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $501K | -0.6% | -35% |
| Q2 2026 | $504K | -13% | -40% |
| Q1 2026 | $579K | -3% | -27% |
| Q4 2025 | $598K | -23% | — |
| Q3 2025 | $775K | -9% | — |
| Q2 2025 | $847K | +6% | — |
| Q1 2025 | $797K | — | — |
Q3 2026 at a glance
Viemed Healthcare, Q3 2026: revenue $80.7M (+12% year over year), operating margin 8.6%, net earnings $4.6M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Viemed Healthcare's R&D spending?
Viemed Healthcare's R&D spending was $501K in Q3 2026 (third quarter 2026), -0.6% from Q2 2026.
How has Viemed Healthcare's R&D spending changed?
Over the last 7 quarters it ranged from $501K (Q3 2026) to $847K (Q2 2025).